Genome-Wide Association Study of Alzheimer's Disease Brain Imaging Biomarkers and Neuropsychological Phenotypes in the European Medical Information Framework for Alzheimer's Disease Multimodal Biomarker Discovery Dataset


Por: Homann, J, Osburg, T, Ohlei, O, Dobricic, V, Deecke, L, Bos, I, Vandenberghe, R, Gabel, S, Scheltens, P, Teunissen, CE, Engelborghs, S, Frisoni, G, Blin, O, Richardson, JC, Bordet, R, Lleo, A, Alcolea, D, Popp, J, Clark, C, Peyratout, G, Martinez-Lage, P, Tainta, M, Dobson, RJB, Legido-Quigley, C, Sleegers, K, Van Broeckhoven, C, Wittig, M, Franke, A, Lill, CM, Blennow, K, Zetterberg, H, Lovestone, S, Streffer, J, ten Kate, M, Vos, SJB, Barkhof, F, Visser, PJ, Bertram, L

Publicada: 21 mar 2022
Resumen:
Alzheimer's disease (AD) is the most frequent neurodegenerative disease with an increasing prevalence in industrialized, aging populations. AD susceptibility has an established genetic basis which has been the focus of a large number of genome-wide association studies (GWAS) published over the last decade. Most of these GWAS used dichotomized clinical diagnostic status, i.e., case vs. control classification, as outcome phenotypes, without the use of biomarkers. An alternative and potentially more powerful study design is afforded by using quantitative AD-related phenotypes as GWAS outcome traits, an analysis paradigm that we followed in this work. Specifically, we utilized genotype and phenotype data from n = 931 individuals collected under the auspices of the European Medical Information Framework for Alzheimer's Disease Multimodal Biomarker Discovery (EMIF-AD MBD) study to perform a total of 19 separate GWAS analyses. As outcomes we used five magnetic resonance imaging (MRI) traits and seven cognitive performance traits. For the latter, longitudinal data from at least two timepoints were available in addition to cross-sectional assessments at baseline. Our GWAS analyses revealed several genome-wide significant associations for the neuropsychological performance measures, in particular those assayed longitudinally. Among the most noteworthy signals were associations in or near EHBP1 (EH domain binding protein 1; on chromosome 2p15) and CEP112 (centrosomal protein 112; 17q24.1) with delayed recall as well as SMOC2 (SPARC related modular calcium binding 2; 6p27) with immediate recall in a memory performance test. On the X chromosome, which is often excluded in other GWAS, we identified a genome-wide significant signal near IL1RAPL1 (interleukin 1 receptor accessory protein like 1; Xp21.3). While polygenic score (PGS) analyses showed the expected strong associations with SNPs highlighted in relevant previous GWAS on hippocampal volume and cognitive function, they did not show noteworthy associations with recent AD risk GWAS findings. In summary, our study highlights the power of using quantitative endophenotypes as outcome traits in AD-related GWAS analyses and nominates several new loci not previously implicated in cognitive decline.

Filiaciones:
Homann, J:
 Univ Lubeck, Lubeck Interdisciplinary Platform Genome Analyt L, Lubeck, Germany

Osburg, T:
 Univ Lubeck, Lubeck Interdisciplinary Platform Genome Analyt L, Lubeck, Germany

Ohlei, O:
 Univ Lubeck, Lubeck Interdisciplinary Platform Genome Analyt L, Lubeck, Germany

Dobricic, V:
 Univ Lubeck, Lubeck Interdisciplinary Platform Genome Analyt L, Lubeck, Germany

Deecke, L:
 Univ Lubeck, Lubeck Interdisciplinary Platform Genome Analyt L, Lubeck, Germany

Bos, I:
 Maastricht Univ, Alzheimer Ctr Limburg, Sch Mental Hlth & Neurosci, Dept Psychiat & Neuropsychol, Maastricht, Netherlands

 Vrije Univ Amsterdam, Amsterdam Neurosci, Amsterdam Univ Med Ctr, Dept Neurol,Alzheimer Ctr Amsterdam, Amsterdam, Netherlands

Vandenberghe, R:
 Katholieke Univ Leuven, Dept Neurosci, Lab Cognit Neurol, Leuven, Belgium

 Univ Hosp Leuven, Neurol Serv, Leuven, Belgium

Gabel, S:
 Katholieke Univ Leuven, Dept Neurosci, Lab Cognit Neurol, Leuven, Belgium

Scheltens, P:
 Vrije Univ Amsterdam, Amsterdam Neurosci, Amsterdam Univ Med Ctr, Dept Neurol,Alzheimer Ctr Amsterdam, Amsterdam, Netherlands

Teunissen, CE:
 Vrije Univ, Amsterdam Univ Med Ctr, Amsterdam Neurosci, Neurochem Lab,Dept Clin Chem, Amsterdam, Netherlands

Engelborghs, S:
 Univ Antwerp, Dept Biomed Sci, Antwerp, Belgium

 Univ Ziekenhuis Brussel, Dept Neurol, Brussels, Belgium

 Univ Ziekenhuis Brussel, Ctr Neurosci, Brussels, Belgium

 Vrije Univ Brussel VUB, Brussels, Belgium

Frisoni, G:
 Univ Geneva, Dept Psychiat, Geneva, Switzerland

 IRCCS Ist Ctr San Giovanni Dio Fatebenefratelli, Brescia, Italy

Blin, O:
 AIX Marseille Univ, Inst Neurosci Timone, Marseille, France

Richardson, JC:
 GlaxoSmithKline R&D, Neurosci Therapeut Area, Stevenage, Herts, England

Bordet, R:
 Univ Lille, Lille Neurosci & Cognit, INSERM, CHU Lille, Lille, France

Lleo, A:
 Hosp Santa Creu & Sant Pau, Dept Neurol, Memory Unit, Barcelona, Spain

 Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain

Alcolea, D:
 Hosp Santa Creu & Sant Pau, Dept Neurol, Memory Unit, Barcelona, Spain

 Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain

Popp, J:
 Univ Hosp Psychiat Zurich, Dept Geriatr Psychiat, Zurich, Switzerland

 Univ Hosp Lausanne, Dept Psychiat, Old Age Psychiat, Lausanne, Switzerland

Clark, C:
 Univ Hosp Psychiat Zurich, Dept Geriatr Psychiat, Zurich, Switzerland

Peyratout, G:
 Univ Hosp Lausanne, Dept Psychiat, Old Age Psychiat, Lausanne, Switzerland

Martinez-Lage, P:
 CITA Alzheimer Fdn, Ctr Res & Adv Therapies, Dept Neurol, Donostia San Sebastian, Spain

Tainta, M:
 CITA Alzheimer Fdn, Ctr Res & Adv Therapies, Dept Neurol, Donostia San Sebastian, Spain

Dobson, RJB:
 Kings Coll London, Inst Psychiat Psychol & Neurosci IoPPN, Dept Biostat & Hlth Informat, London, England

 South London & Maudsley NHS Fdn Trust, NIHR Biomed Res Ctr, London, England

 Kings Coll London, London, England

 UCL, Hlth Data Res UK London, London, England

 UCL, Inst Hlth Informat, London, England

 Univ Coll London Hosp NHS Fdn Trust, NIHR Biomed Res Ctr, London, England

Legido-Quigley, C:
 Steno Diabet Ctr, Copenhagen, Denmark

 Kings Coll London, Inst Pharmaceut Sci, London, England

Sleegers, K:
 Univ Antwerp, Dept Biomed Sci, Antwerp, Belgium

 VIB, Ctr Mol Neurol, Complex Genet Alzheimers Dis Grp, Antwerp, Belgium

Van Broeckhoven, C:
 Univ Antwerp, Dept Biomed Sci, Antwerp, Belgium

 VIB, Ctr Mol Neurol, Neurodegenerat Brain Dis Grp, Antwerp, Belgium

Wittig, M:
 Christian Albrechts Univ Kiel, Inst Clin Mol Biol, Kiel, Germany

Franke, A:
 Christian Albrechts Univ Kiel, Inst Clin Mol Biol, Kiel, Germany

Lill, CM:
 Univ Lubeck, Lubeck Interdisciplinary Platform Genome Analyt L, Lubeck, Germany

 Imperial Coll London, Sch Publ Hlth, Ageing Epidemiol Res Unit, London, England

Blennow, K:
 Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, Gothenburg, Sweden

 Sahlgrens Univ Hosp, Clin Neurochem Lab, Molndal, Sweden

Zetterberg, H:
 Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, Gothenburg, Sweden

 Sahlgrens Univ Hosp, Clin Neurochem Lab, Molndal, Sweden

 UCL, Dept Neurodegenerat Dis, Queen Sq Inst Neurol, Queen Sq, London, England

 UCL, UK Dementia Res Inst, London, England

Lovestone, S:
 Univ Oxford, Dept Psychiat, Oxford, England

Streffer, J:
 Univ Antwerp, Inst Born Bunge, Reference Ctr Biol Markers Dementia BIODEM, Antwerp, Belgium

 Janssen R&D LLC, Beerse, Belgium

 AC Immune SA, EPFL Innovat Pk, Lausanne, Switzerland

ten Kate, M:
 Katholieke Univ Leuven, Dept Neurosci, Lab Cognit Neurol, Leuven, Belgium

 Univ Amsterdam, Med Ctr, Amsterdam Neurosci, Dept Radiol & Nucl Med, Amsterdam, Netherlands

Vos, SJB:
 Maastricht Univ, Alzheimer Ctr Limburg, Sch Mental Hlth & Neurosci, Dept Psychiat & Neuropsychol, Maastricht, Netherlands

Barkhof, F:
 Univ Amsterdam, Med Ctr, Amsterdam Neurosci, Dept Radiol & Nucl Med, Amsterdam, Netherlands

 UCL, Inst Neurol, London, England

 UCL, Inst Healthcare Engn, London, England

Visser, PJ:
 Maastricht Univ, Alzheimer Ctr Limburg, Sch Mental Hlth & Neurosci, Dept Psychiat & Neuropsychol, Maastricht, Netherlands

 Katholieke Univ Leuven, Dept Neurosci, Lab Cognit Neurol, Leuven, Belgium

 Karolinska Inst, Div Neurogeriatr, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden

Bertram, L:
 Univ Lubeck, Lubeck Interdisciplinary Platform Genome Analyt L, Lubeck, Germany

 Univ Oslo, Dept Psychol, Oslo, Norway
ISSN: 16634365
Editorial
FRONTIERS MEDIA SA, AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND, Suiza
Tipo de documento: Article
Volumen: 14 Número:
Páginas:
WOS Id: 000784330000001
ID de PubMed: 35386118
imagen Green Published, gold

MÉTRICAS